Core Viewpoint - Carvana Co. reported stronger-than-expected revenue but faced challenges from rising operational costs and scrutiny from short sellers [1][2]. Quarterly Performance - Carvana's fourth-quarter revenue reached nearly $5.6 billion, exceeding analyst expectations of approximately $5.26 billion [2]. - The company reported earnings of $4.22 per share [2]. - Increased costs related to vehicle inspections, repairs, and detailing impacted profitability, alongside higher retail depreciation affecting per-unit economics [2]. Growth Strategy and Long-Term Targets - Executives outlined plans to enhance retail sales volume and adjusted EBITDA through 2026, anticipating sequential improvements in the first quarter as operational efficiency increases [3]. - CEO Ernie Garcia stated the goal of selling 3 million retail units annually with a 13.5% Adjusted EBITDA margin by 2030 to 2035 [3]. Profitability and Inventory Management - The company aims to focus on scalable profitability while ensuring disciplined inventory management [4]. Short Seller Claims Rejected - Carvana refuted allegations from Gotham City Research regarding overstated earnings for 2023-2024 by over $1 billion and reliance on related parties for financial stability [5]. - The company indicated that all related-party transactions are properly disclosed [6]. Analyst Opinions - Needham analyst Chris Pierce maintained a Buy rating with a price target of $500 [7]. - BTIG analyst Marvin Fong also maintained a Buy rating but reduced the price target from $535 to $455 [7]. - Carvana shares experienced a decline of 16.57%, trading at $301.61 during premarket [7].

Core Insights - Earth Science Tech, Inc. has engaged Hayden IR to enhance its investor relations and market awareness initiatives, following the successful completion of its FINRA 15c-211 clearance, which supports the company's strategy to scale its businesses into cash-generating entities [1][2] Company Overview - Earth Science Tech operates as a strategic holding company focused on value creation through the acquisition and management of its subsidiaries, which include compounding pharmaceuticals, telemedicine, and real estate development [5][10] - The company's subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, each contributing to its diversified business model [5][10] Financial Performance - In the first half of fiscal 2026, Earth Science Tech reported revenues of $17.8 million, net income of $1.4 million, and operating cash flow of $1.18 million, with gross margins exceeding 70% [3] - The company is noted to have significant operating leverage, indicating potential for higher earnings with rationalized expenses [3] Strategic Initiatives - The partnership with Hayden IR aims to develop a comprehensive investor relations program, focusing on clear communication of the company's strategy, performance, and long-term value proposition [2] - Hayden IR will assist in outreach to both institutional and retail investors, corporate access initiatives, and support for public disclosures and market education [2] Market Positioning - The CEO of Earth Science Tech emphasizes the importance of clearly communicating the company's current operations and growth strategy to the investment community as it enters a critical phase of market repositioning [2]